Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
13,304,959
-
Share change
-
+543,444
-
Total reported value
-
$1,215,500,228
-
Put/Call ratio
-
178%
-
Price per share
-
$91.37
-
Number of holders
-
107
-
Value change
-
+$42,362,657
-
Number of buys
-
58
-
Number of sells
-
42
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q3 2015
As of 30 Sep 2015,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
107 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,304,959 shares.
The largest 10 holders included
Capital Research Global Investors, FMR LLC, PRUDENTIAL PLC, JANUS CAPITAL MANAGEMENT LLC, Bank of New York Mellon Corp, BANK OF AMERICA CORP /DE/, FEDERATED INVESTORS INC /PA/, Capital World Investors, DEERFIELD MANAGEMENT CO, and ORBIMED ADVISORS LLC.
This page lists
107
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.